Calistoga in drug trials for lymphoma and leukemia treatments

Discussion in 'Health and Wellness Forum' started by Terry, Jun 30, 2010.

  1. Terry

    Terry Administrator Staff Member

    Aug 17, 2004
    Bothell, Washington
    CAL-101 is designed to treat two forms of lymphoma and one form of leukemia. In prior clinical trials, according to Calistoga, nearly 60 percent of non-Hodgkins lymphoma patients responded to the treatment, as well as almost 70 percent of mantle cell lymphoma patients and 30 percent of leukemia patients. Responses ranged from a tumor shrinking to the cancer going into remission for up to a year.

    The story here
  2. Cookie

    Cookie .

    Oct 7, 2005
    I love it. I love hearing stuff like that, it excites me. My uncle passed away with Leukemia and as you know I battle NHL. BUT, I got great news! I got my dancing shoes on and my party dress. My scans from the other day, the CT's showed no change since over a year ago. ACTUALLY, since 4 years ago.

    So, my friend, I am here to pester you just a tadbit longer, maybe, another 100 years.

    Wha cha say to that?

  3. Sponsor

    Sponsor Paid Advertisement

Similar Threads: Calistoga drug
Forum Title Date
Health and Wellness Forum Plan for lowering BIG PHARMA drug prices comes at a high cost Feb 4, 2017
Health and Wellness Forum Company Hikes Price 5,000% For Life-Saving Cancer and AIDS Drug Sep 19, 2015

Share This Page